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Almost  all our detailed knowledge about the endothelium 
is  proximate knowledge about its structure,  development, 
and functioning, and how its dysfunctions lead to disease. 
The other, evolutionary half of endothelial biology has been 
neglected.  Some researchers  are unfamiliar  with  the  fun- 
damental distinction between  proximate and  evolutionary 
questions, and methods for formulating and testing evolu- 
tionary hypotheses about the endothelium remain underap- 
preciated.  This chapter offers a brief overview  ofthe distinction 
between evolutionary and proximate explanations, followed 
by an introduction to evolutionary medicine and its applica- 
tions to the endothelium. 
Evolutionary, or Darwinian, medicine simply brings the 
power of evolutionary biology to bear on the problems of 
medicine. Some areas, such as pathogen evolution and pop- 
ulation genetics, are well developed. Another aspect, empha- 
sized in Darwinian medicine, is the enterprise of formulating 
and testing hypotheses about why natural selection has not 
shaped bodies that are more resistant to disease. The six key 
reasons for traits that leave bodies vulnerable to disease are 
reviewed below. Each is illustrated with examples from gen- 
eral medicine, and then with examples from a major disease 
of the endothelium, atherosclerosis. 
TWO SEPARATE BIOLOGICAL QUESTIONS 
Ernst Mayr passed away early in 2005 at age 100, shortly after 
publishing his twentieth book and the last of his 700+  scien- 
tific articles. One of his enduring contributions  was his dogged 
emphasis on the importance of distinguishing proximate from 
evolutionary (sometimes called ultimate) biological explana- 
tions. His treatise, The Growth of  Biological Thought, traces 
these 'two only-occasionally intersecting threads in biology: 
one that studies how things work (proximate), the other that 
studies why organisms are the way  they are (evolutionary) 
(1). His final book,  What Makes Biology  Unique,  continues 
and updates the theme (2). Over and over again, he makes the 
point that every biological trait needs both a proximate expla- 
nation of its structure and operation, and an evolutionary 
explanation of why it is the way it is. For example, an expla- 
nation of the structure of chlorophyll and how it captures 
photons and traps their energy in chemical bonds is essential. 
Equally important, however, is an evolutionary explanation 
of the biological history of chlorophyll and how its particular 
form gives a selective advantage. As many will know, the story 
is intriguing, with the machinery for photosynthesis evolving 
in one-celled organisms about 3.5 billion years ago, probably 
in the precursors to cyanobacteria. It has been only about 1  bil- 
lion years, however, since those organisms were incorporated 
into the eukaryotic cell as chloroplasts. A complete biological 
explanation of chlorophyll  needs both a proximate description 
of how chloroplasts  work, and an evolutionary explanation of 
the selection forces and phylogenetic pathways that gave them 
their current characteristics,  instead of others. 
The distinction between "how" and "why" questions was 
developed further by Tinbergen, in a seminal  article describing 
his famous "Four Questions" (3). Here, he divides proximate 
questions into two subtypes: those about the structure of a 
trait and those about its ontogeny. He also divides evolution- 
ary questions into those about how a trait gives a selective 
advantage  and those about the phylogeny of a trait. Implicit in 
this classification is the need to address four separate questions 
when offering a full biological explanation for any trait. All 
too often, the four questions are inadequately distinguished 
or incorrectly taken to be alternatives. Sometimes the evo- 
lutionary questions are not taken seriously or are ignored 
completely. 
Much of this situation is understandable because edu- 
cation about these aspects of evolutionary biology often is DARWINIAN MEDICINE 
limited,  even  for  some  biologists.  It  remains  lamentable 
nonetheless.  Biology would progress faster if  evolutionary 
questions about every trait were addressed systematically. In 
medicine, this is of particular importance. Many physicians 
have  nayve  notions about the body,  such as the belief that 
a normal genome exists, or that the body is designed like a 
machine, or that its flaws result mainly from the limited pow- 
ers of natural selection. Asking evolutionary questions reveals 
that the body is a bundle oftrade-offs, with no  trait perfect, and 
substantial vulnerabilities  persisting not just because selection 
is too weak, but also for several other reasons. 
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' In  the past decade, rapid progress has been made in using 
evolutionary principles to understand why bodies are so vul-  !  nerable to disease (4-8).  The obvious explanation, the limits of  1  natural selection in the face of mutation and drift, is certainly 
1  important. However, five additional reasons must be consid- 
I  ered in any assessment ofwhy a trait appears suboptimal. Each 
of these reasons deserves separate consideration for medical 
conditions in general, and for aspects of the endothelium in 
:  particular. 
Novel Environments 
Much, even most, of modern chronic disease arises because 
we  live in environments far different from those our bodies 
were  selected for (see Chapter 16). Paradoxically, our great- 
est  threats now come from our grand success at providing 
ourselves with all manner of tasty food available with little 
effort at any time. A third of adults are overweight in many 
developed countries, and rates of obesity are rising quickly 
everywhere food is plentiful, giving rise to Syndrome  X and all 
its complications (9). The preferences that shaped our current 
food supply shape our personal dietary habits. On the African 
savannah, tendencies to eat fat, sugar, and salt and minimize 
exercise were generally useful; today, they are fatal (10). 
Infection and Vulnerabilities from "Arms Racesn 
A second major reason why natural selection cannot make 
bodies that defend themselves better from disease is because 
natural selection is simultaneously making other organisms 
better able to penetrate  defenses (11). Worse yet, the rate 
of  evolution in bacteria and viruses is orders of magnitude 
faster than is the rate for slowly reproducing organisms such 
as humans. 
Limits on  What Selection Can Do 
This brings us to what selection can and cannot do. Some sci- 
entists attribute flaws in the organism mainly to the inevitabil- 
ity of mutations and the slow rate at which selection  can purge 
them from the gene pool. Such mutations and the limited 
speed of selection are indeed significant factors explaining the 
body's imperfections. However, they are by no means the only 
or  the most important factors. Furthermore, their importance 
often is overrated by those who hold fundamentally mistaken 
views, such as that the body is a well-designed machine, or 
that there exists a single normal genotypelphenotype. The 
body does work like a machine, but its origins were far differ- 
ent from any design shaped with the forethought of an engi- 
neer. It is cluttered with remnants of previous features that 
limit optimality. Consider the path of the recurrent laryn- 
geal nerve, from the brainstem all the way down to just above 
the lung, where it wraps around the subclavian artery before 
ascending again to pass behind the thyroid gland on the way 
to the larynx. The vas deferens makes an equally circuitous 
path (12). Such "design flaws" exist because the body is pro- 
foundly path-dependent:  Just like the arrangement  of keys 
on a typewriter keyboard, once structures are in a particular 
conformation, changing them can be very expensive  or impos- 
sible. An automobile designer can move the gasoline tank if it 
proves vulnerable to rupture, but natural selection can never 
alter the awkward and dangerous path of childbirth through 
the narrow ring of the pelvis. 
Trade-offs 
Trade-offs are another source of traits that seem less than per- 
fect. Here the problem is the same as that faced by any human 
designer. No trait can ever be completely perfect because at 
some point making one trait better will make others worse. 
Bones could be thicker, but they would then be heavier and less 
mobile. Joints could be more flexible, but that would risk dam- 
age to muscles. The immune system could be more aggressive 
but only at the cost of constant tissue damage. 
Selection Maximizes Reproduction, Not Health 
It is a common mistake to think that the body is designed for 
health, and all disease arises from design flaws. Actually, bodies 
are products of evolution, not design. They are merely pheno- 
types that maximize  the transmission of genes (  13,14). If a gene 
increases reproductive success, it will spread, even if it causes 
disease or shortens life. Aging itself may result, in part, from 
pleiotropic genes that cause aging but that are nonetheless 
selected for because they give a benefit in youth when selection 
is strong (15,16). Likewise, much of the increased mortality 
in males compared to females comes from the reproductive 
benefits of increased allocation of effort to competition at the 
expense of tissue repair (17). Increased reproduction at the 
expense of health does not seem to be an obvious major fac- 
tor in shaping the endothelium, but men develop atheroscle- 
rotic disease more rapidly than do females, almost certainly 
because sexual selection has resulted in systems that allocate 
more effort to competition and less to tissue protection and 
repair in males as compared with females (1  7,18). In particu- 
lar, traits that benefit a fetus may be selected for, even if they 
damage the mother. ENDOTHELIAL BIOMEDICINE 
Defenses Are Useful Despite Their Costs 
Finally, there exist the body's many protective responses such 
as pain, fever, vomiting, cough, and inflammation. Although 
they cause suffering and often bodily damage, they are use- 
ful responses, not defects. Their costs are trade-offs for the 
benefits they offer. It is all too easy to imagine that defenses 
are problems. For instance, the fever, pain, fatigue, and cough 
that accompany a cold do not seem to be obviously useful. 
This "clinician's illusion" that they are problems is bolstered 
because blocking them with drugs seems to cause few compli- 
cations. However, this is only because the body has so many 
redundant defense systems, and because the systems that reg- 
ulate defense expression are shaped to express defenses when- 
ever that is worthwhile. If there is any uncertainty in when to 
express them, this means a normal system will have many false 
alarms. Many defenses, such as vomiting or  panicked flight,  are 
quite inexpensive compared to the huge cost ofnot responding 
to a real danger such as intestinal infection or an approaching 
tiger. The defense should be expressed whenever the average 
benefit is greater than the average cost, so many false alarms 
are normal and to be expected. This has been called "The 
Smoke Detector Principle," because we tolerate false alarms 
from burnt toast to ensure that the alarm sounds every sin- 
gle time even a small fire occurs (19). Disrupting defenses is 
not, however, completely benign; using drugs to block fever, 
cough, or diarrhea can lead to serious consequences (6). 
EVOLUTIONARY ANALYSIS OF ENDOTHELIAL 
DYSFUNCTION AND ATHEROSCLEROSIS 
The healthy endothelium contributes  to several processes 
of obvious adaptive advantage: control of hemostasis, pro- 
tection of subendothelial structures from circulating blood, 
local  modulation  of  hemodynamics,  and  defense against 
infection. Endothelial dysfunction, broadly defined, can be 
lethal, as evidenced by von Wiebrand disease and endo- 
toxic shock. Subtler endothelial dysfunction is characteristic 
of early atherosclerosis,  an important disease of the developed 
world. Although we cannot know for certain, it is unlikely that 
atherosclerosis caused significant morbidity or mortality in 
the pre-agricultural era, and indeed modern hunter-gatherers 
are little affected by atherosclerosis (see Chapter 16). How- 
ever, atherosclerosis is now epidemic in developed societies 
worldwide, suggesting a near universal predisposition for the 
disease, with some of the variation in vulnerability arising 
from genetic differences. Although some common vulnera- 
bility factors, such as low levels of high-density lipoprotein 
(HDL) cholesterol, may result from the accumulation of mul- 
tiple rare alleles in a specific population, most probably they 
result from common allelic variants found in all populations 
(20). The apolipoprotein E story is particularly germane in 
this regard (21). Common and widely dispersed genetic pat- 
terns are of ancient origin, and thus presumably predispose 
all humans to disease susceptibility when they interact with 
modern conditions. Indeed, even in recent historical times, 
transitions  from relatively low to high rates of atheroscle- 
rosis  have  been  observed  to  accompany cultural  transi- 
tions. 
At  this  early juncture,  it is  important  to acknowledge 
explicitly that we do not propose that "genes for atherosclero- 
sis" exist. Rather, we believe that those suites of genes, shared 
by most of us, that now exact a net cost were preserved because 
they have yielded a net benefit over evolutionary time. This 
may be because dietary changes interact with these genes to 
impose costs throughout life, or because the benefits dur- 
ing early life are larger for some genes than are their adverse 
consequences  during adulthood (antagonisticpleiotropy). The 
massive amount of work constituting the bulk of the current 
volume provides insights about the proximate mechanisms 
by which atherosclerosis arises and progresses, and we draw 
heavily on that mechanistic knowledge. Our task is to suggest 
reasons why natural selection over the past hundred thousand 
years conserved an essentially universal vulnerability to such 
an important disease process. 
Although early atherosclerosis usually is characterized as 
"endothelial dysfunction," and the progression of atheroscle- 
rosis as a "response to  injury," close examination ofearly events 
shows the endothelium to be functioning in a largely normal 
manner, at least as regards one of its primary functions - 
immunity. For most of hominid history, infections have rep- 
resented grave threats, whether arising from injury, peripar- 
tum infection, or endemic pathogens. The nature, although 
not the risk, of  infectious disease changed as settled com- 
munities developed (1  1). Increased population density per- 
mitted human-to-human disease transmission, leading to the 
rise of epidemic disease, and animal domestication led to the 
emergence of novel zoonoses, especially evident now as avian 
influenza  threatens. Innate and acquired immunological func- 
tions that eliminate  or suppress  infections are highly conserved 
as powerful and often apparently redundant defenses. The evo- 
lution of such systems cannot reasonably be attributed to any- 
thing other than incremental beneficial genetic changes that 
improved the reproductive success of those individuals who 
had them. The endothelium contributes very importantly to 
immunity, and one of its functions -  the controlled trans- 
port of intravascular substances and cells to the subendothe- 
lial space -  seems  to predispose us to  atherosclerosis. Although 
this could be interpreted as a simple defect, it appears much 
more like an adaptation that has benefits that are equal to or 
greater than its costs in a classic trade-off. 
Atherosclerotic lesions begin as low-density lipoprotein 
(LDL) particles accumulate in the subintimal space (22). The 
concentration  of  LDL  in the blood is an important deter- 
minant  of the rate  of  accumulation,  as is the concentra- 
tion of HDL available for reverse cholesterol transport out 
of the tissue. However, the trafficking of lipoproteins across 
the endothelium is not passive. Rather, LDL and HDL cross 
endothelial cells (ECs) by means of pinocytosis, which allows 
the delivery oftriglycerides and cholesterol  for metabolic sup- 
port, cell growth, and steroidogenesis. ENDOTHELIAL BIOMEDICINE 
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immunity, and one of its functions -  the controlled trans- 
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this could be interpreted as a simple defect, it appears much 
more like an adaptation that has benefits that are equal to or 
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Atherosclerotic lesions begin as low-density lipoprotein 
(LDL) particles accumulate in the subintimal space (22). The 
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port, cell growth, and steroidogenesis. DARWINIAN 
The  macrophage  is  another  key  player  in  atheroscle- 
rosis  (22,23). Although macrophages normally resident in 
the subintima can handle some foreign antigens, the local 
response to tissue infection triggers an elaborate signaling 
system marshalling a defense reaction that includes the trans- 
endothelial migration of large numbers ofmonocytes and sub- 
sequent differentiation into macrophages to engulf bacteria 
and expose them to lysosomal enzymes. Macrophage phago- 
cytosis and the intracellular lysosomal degradation of bacte- 
ria are efficient, but via coevolution, some organisms have 
derived strategies to frustrate macrophage capabilities. Thus, 
although bacteria that can be opsonized are cleared efficiently, 
many bacteria (e.g.,  Listeria and tuberculosis) have evolved 
resistance to the constitutive killing mechanisms used  by 
macrophages such that they can survive, even intracellularly. 
Chlamydia-pneumoniae may be of particular importance (24). 
The process of the development of bacterial resistance is 
reminiscent of how LDL  particles take up residence in the 
subendothelium, escape macrophage metabolism, and cause 
disease. Native LDL particles attach to macrophage LDL recep- 
tors and are efficiently engulfed and metabolized, just as bac- 
teria are. As  part of this normal process, macrophage LDL 
receptors are down regulated and, in consequence, individ- 
ual macrophages do not become overloaded with LDL parti- 
cles. However, under oxidizing conditions, LDL particles are 
transformed to oxidized LDL particles that are taken up by 
macrophages via alternative high-capacity scavenger recep- 
tors (CD36 and type A scavenger receptor [SR-A])  normally 
employed for the ingestion of bacteria. These receptors are 
not down-regulated by the accumulation of oxidized LDL; 
macrophages continue to accumulate lipoprotein moieties in 
a relatively unregulated manner, leading to the cellular con- 
gestion evident in foam cells (22). Note, however, that during 
the early stages, both ECs and macrophages are doing what 
they are well adapted to do: that is, prevent invasion by micro- 
scopic threats. It is probably only in our modern environment 
that these processes are corrupted by excess lipoprotein levels 
and oxidative stress that leads to disease. 
While  macrophage functions  are being subverted, the 
endothelium overlying the early atherosclerotic  lesion is intact 
and functional. Indeed, it appears that the normal vessel is 
able to heal the early effects of subintimal foam cell accumula- 
tion. Fetuses show foam cell lesions, termed "fatty streaks," 
during  early  development,  particularly  in  hyperlipidemic 
mothers in which the fetal blood cholesterol level correlates 
closely with that of the mother (25). These early fatty streaks 
appear to regress later in pregnancy either as fetal choles- 
terol demand decreases or fetal production increases; fetal 
cholesterol requirements become less dependent on maternal 
sources, and fetal blood cholesterol concentration is no longer 
correlated with that of the mother. The initial accumulation 
probably reflects an example of fetal-maternal  conflict: The 
rapidly developing fetus requires more cholesterol than it can 
synthesize and is dependent on transplacental delivery, thus 
creating a potential conflict with the mother who could use 
these caloric resources for herself or a subsequent offspring. 
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David Haig has pioneered this line of thought (26), as exem- 
plified  in his chapter in this volume on such conflicts and 
their role in preeclampsia (Chapter 17). The consequences of 
poor fetal lipoprotein access are profound: Cholesterol defi- 
ciencies in the mother can cause severe fetal developmental 
defects, particularly in the lipid-rich brain. Not all the vascu- 
lar changes in the fetus may be reversible, however, because 
postnatal atherogenesis may be accelerated in the offspring 
of hypercholesterolemic mothers who develop hypercholes- 
terolemia themselves (27). 
In part, the healing process itself may induce atherosclero- 
sis. Lipoprotein(a) is an LDL-like particle with putative roles 
in tissue repair and inhibition of fibrinolysis  that may also act 
as a surrogate for vitamin C in animals that have lost the ability 
to synthesize the vitamin de novo. Lipoprotein(a) is limited 
to a subgroup of primates (and interestingly appears to have 
evolved independently in the hedgehog) in which it may have 
evolved when injuries resulted from trauma and infection. 
When expressed in a modern milieu, in which  endothelial 
dysfunction is widespread (27), the actions of lipoprotein(a) 
promote atherosclerosis. In fact, just as for macrophages and 
the endothelium, lipoprotein(a) is doing what it does best - 
trying to heal injury. 
The aspects of the modern environment predisposing to 
atherosclerosis  in the developed world are well known: dietary 
excess, sedentary lifestyle, cigarette smoking, air pollution, 
and diabetes, in addition to the acquired lipoprotein disor- 
ders of high LDL  and low HDL concentrations. Although it 
is clear that the nonlipid risk factors can result in endothe- 
lial dysfunction, as evidenced by diminution of flow-mediated 
dilatation or responses to  infused acetylcholine, it appears that 
atherosclerosis develops only in the face of the lipid disor- 
ders. The key player is almost certainly LDL -  isolated low 
HDL-cholesterol or high blood pressure in knockout mice 
without LDL are incapable of causing atherosclerosis; high 
LDL cholesterol seems to be the sine qua non of atheroscle- 
rosis. However, native LDL-cholesterol itself does not appear 
to be sufficient for triggering atherosclerosis; there appears to 
be a requirement for oxidation. As noted above, LDL oxida- 
tion seems to be a key feature of the macrophage's inability 
to regulate LDL particle uptake, and oxidation likewise plays 
an important role in the progression of lesions by stimulating 
subintimal lipoprotein retention, cytokine elaboration, and 
the chemoattraction  of participating inflammatory cells by 
macrophages. Oxidized LDL uptake is one of the factors pro- 
moting the release of inflammatory mediators. The inflam- 
matory response decreases nitric oxide (NO) production and 
contributes to "endothelial dysfunction" (by which is meant 
the vasodilator response to NO-mediated agonists) (28). 
Macrophage responses may not be confined to vessels, as 
recently suggested by observations of macrophage infiltration 
into adipose tissue, where elaboration of cytokines also occurs. 
Lerke and Lazar (29) have recently suggested the possibility 
that fat cells are recognized as invaders by macrophages, trig- 
gering responses similar to those causing atherosclerosis. If so, 
the sequence would add credence to the idea that macrophage ENDOTHELIAL BIOMEDICINE 
activity  and its attendant ill effects on the endothelium are con- 
served evolutionary responses of broad utility that are ren- 
dered harmful by modern environments. Although many as- 
pects of the environment contribute to atherosclerosis, all seem 
to operate through LDL oxidation which, in a sense, serves to 
protect LDL particles from intracellular metabolism and, in 
that way, mimics one of the strategies followed by bacteria. 
Returning to the question of why this most useful process 
has come to cause atherosclerosis, the most obvious factor 
is the level and kinds of lipids characteristic in contempo- 
rary human diets. Hunter-gather and traditional rural soci- 
eties have serum cholesterol  levels far below those of Western- 
ized populations. Indeed, less than 5% of adults in the United 
States have a total cholesterol ofless than 150 mg/dL, the aver- 
age value in the more biologically "normal" populations (30). 
Thus, in essence, almost everyone in the United States, and in 
many other Westernized countries, is hypercholesterolemic, 
and the situation for triglycerides is similar. Undoubtedly, our 
societal  hyperlipidemias are overwhelmingly  due to diet, both 
its macronutrient composition and its caloric excess, particu- 
larly when such a diet is coupled with a sedentary lifestyle. The 
effect of modern lifestyle is Syndrome X, which in addition 
to promoting hyperlipidemia also increases oxidative stress, 
resulting in increased levels of atherogenic oxidized LDL (31). 
One way of thinking about atherosclerosis is to view it as 
the result of an evolved adaptive response that protects against 
infection but that results in endothelial injury in modern envi- 
ronments. Because the consequences of the injury occur late 
in life, natural selection preserves those systems promoting 
atherosclerosis  in preference  to those suppressing  them, a clas- 
sic case of antagonistic pleiotropy. This is a trade-off, but not 
quite a classic one. Because the costs were probably minimal 
until the past century, and because they caused no harm until 
modern times, the genetic variations that increase vulnerabil- 
ity to atherosclerosis are not really "defects," but are instead 
excellent examples of "genetic quirks" that give rise to unto- 
ward effects only when they interact with factors encountered 
in modern environments. These speculations about the adap- 
tive roots of atherosclerosis  give rise to a specific  prediction that 
individuals who have a genetic predisposition to atheroscle- 
rosis may be less vulnerable to infection and more susceptible 
to other inflammatory diseases. In regards to the question 
of autoimmune diseases, data demonstrate a strong associa- 
tion between rheumatoid arthritis and accelerated atheroscle- 
rosis (32), although the authors of that article suggest that 
the chronic low-grade inflammation of arthritis activates the 
atherosclerotic  process rather than vice versa. In truth, the rela- 
tionship may be bidirectional, with each process reinforcing 
the other. 
The adaptive significance of the systems that leave us vul- 
nerable to atherosclerosis is  only one half of  a full evolu- 
tionary explanation. We  also need to know the phylogeny 
of those systems, and particularly if  path  dependence has 
constrained them so that natural selection cannot shape a 
less vulnerable mechanism. Although it would conceivably be 
possible to develop alternative ways of preserving the func- 
tions of lipoproteins necessary for blood-borne triglyceride 
and cholesterol delivery while preventing excessive pinocy- 
totic delivery to subendothelial spaces, such an adaptation 
would probably seriously compromise cholesterol-dependent 
cellular and immune processes.  Because immune function 
has such obvious selective value -  whereas atherosclerotic 
disease, primarily manifest late in life, presumably is not a 
major selection force -  there would seem to be little tendency 
to shape such an adaptation. However, too much of a good 
thing is dangerous, as illustrated by chronic inflammatory 
diseases such as rheumatoid arthritis accelerating atheroscle- 
rosis. Conversely, in situations in which 'innate immunity is 
compromised (e.g., by inactivating mutations of the Toll-like 
receptor 4 (TLR4) receptor, a pattern  recognition receptor 
involved in lipopolysaccharide clearance), atherosclerosis is 
decreased (33). Thus, in the trade-off of immune function ver- 
sus atherosclerosis, the benefits of immunity provide greater 
advantages early in life when selection is stronger, thus leav- 
ing us with a strong predisposition to atherosclerosis. A signal 
detection analysis of the costs and benefits of various regula- 
tory settings could further illuminate the situation (19). 
Are other evolutionary factors at work?  A direct infectious 
hypothesis has been championed by Ewald, who contends that 
atherosclerosis is triggered by infections that have coevolved 
with humans (24). Ofparticular interest has been the relation- 
ship of Chlamydia pneumoniae, an organism capable of living 
inside inflammatory cells in blood vessel plaques. Ewald sug- 
gests that the bacterial infection, rather than being a bystander 
colonizing a disrupted vascular wall, is pathogenetic. He fur- 
ther notes that in the case of inflammatory arthritis, a higher 
incidence of joint-fluid C. pneumoniae infections are associ- 
ated with a higher prevalence of the apolipoprotein ~4 geno- 
type. Because this is a risk factor for coronary disease, it is 
possible the mechanism mediating risk is an increased suscep- 
tibility to C.pneumoniaeinfection and vascular inflammation. 
Clearly, if true, the early lesions could attract macrophages, 
increase local oxidative activity and, in the presence of LDL 
particles, trigger atherosclerosis. An  attempt at testing this 
hypothesis by treating patients with established atheroscle- 
rosis with antibiotics was negative (34), but. it is still plausi- 
ble to assume that the role of the bacterium is prominent in 
the early disease but not after atherosclerosis has progressed. 
C. pneumoniae is not the only infection thought to accelerate 
atherosclerosis: Many chronic subclinical  infections,  including 
periodontitis, sinusitis, bronchitis, and diverticulitis -  in fact 
any source of chronic endotoxemia -  may provoke an inflam- 
matory response and increase the risk of atherosclerosis (35). 
The other major player in the atherosclerotic picture, HDL, 
may be a defense against atherosclerosis-promoting infectious 
agents by acting as a scavenger of lipopolysaccharide (36). 
CONCLUSION 
The implications of  an evolutionary view of  the endothe- 
lium are several. First and most obviously, in the absence of DARWINIAN MEDICINE 
profound changes in the environment or human nature, it 
is unlikely that atherosclerosis can be prevented in the gen- 
eral population through the public health measures known to 
be effective -  diet and exercise -  although they can be effec- 
tive for those individuals capable of modifying their behavior 
(37). The burgeoning epidemic of obesity suggests that the 
lifestyle causing hyperlipidemia is triumphing to the extent 
I  that reducing cholesterol values to those of hunter-gatherers 
by  lifestyle interventions is simply unrealistic. As a society, 
we  seem to be much more willing, even eager, to embrace 
antiatherosclerotic strategies that depend on the administra- 
tion of costly drugs to already-ill individuals nearing the end 
of  the natural history of atherosclerotic diseases. Given cur- 
rent costs, inequalities in health care delivery, and the poor 
public health infrastructure, such treatments, unfortunately, 
cannot reasonably  be provided for population-wide  treatment 
and, in any case, they are not that effective. More promis- 
,  ing preventive approaches include modifications like statins 
I  and antioxidants, although one line of argument developed 
above suggests the need to be  on guard for the possibility 
that antioxidants may increase other vulnerabilities. Epidemi- 
ological evidence supporting the benefits of dietary antiox- 
idants is encouraging, although the effectiveness of antiox- 
i  idants  in  intervention trials has  been  disappointing (23). 
a  Trials in established atherosclerosis may,  however, be a case 
of too little, too late, as atherogenesis is already well advanced, 
perhaps beyond the period in which antioxidants could be 
effective. What is clear is that only with the development of 
effective preventive approaches that can be widely applied 
will any progress be made in preventing the complications of 
atherosclerosis. 
One potentially beneficial feature of modern society is 
found in Barker's hypothesis, which implies that improved 
maternal nutrition may decrease the development of features 
described  as the "thrifty phenotype" - a set of  metabolic 
adjustments programmed to promote calorie retention but 
which  increase the risk of  late-life atherosclerosis (38,39). 
Unfortunately, to realize the benefits of improved maternal 
nutrition, the environment of the offspring throughout life 
would have to promote avoidance of calories and fat excess, 
which again seems impracticable. 
Genetic engineering  has been held out as a possible cure for 
atherosclerosis. We believe the evidence is overwhelming  that 
only a small min the focus on "gene hunting" for atheroscle- 
rosis should therefore be on finding common allelic variants 
or haplotypes controlling "normal" homeostatic functions. 
This is not to say that elucidation of monogenic diseases will 
not lead to a better understanding of the vulnerabilities of 
atherosclerotic disease progression, just as a molecular under- 
standing of the LDL receptor in familial hypercholesterolemia 
contributed so importantly to the development of drugs useful 
in preventing further progression of atherosclerosis.  The iden- 
tification of the Milano Apo A1 mutation (40), which exerts a 
powerful protective effect against atherosclerosis by markedly 
enhancing reverse cholesterol transport and presumably act- 
ing to heal the early atherosclerotic lesions before the sequence 
of reinforcing mechanisms is recruited, may be another exarn- 
ple of how a monogenic disease can inform the development 
of prevention strategies. 
Just as genetic determinants are likely to be "normal" alle- 
les, normal immune processes predispose to atherogenesis. 
Could atherosclerosis be prevented by the selective modula- 
tion of immune function, specifically the physiological func- 
tions of macrophages involved in atherogenesis?  Similarly,  per- 
haps endothelial  transport of LDL molecules can be targeted. 
The endothelium has its own protective mechanisms against 
the transport  of larger lipoproteins such as very-low den- 
sity lipoprotein (VLDL). Perhaps a "vaccination" that slowed 
LDL-cholesterol transport could have  promise for slowing 
atherosclerosis.  Ceruloplasmin  is a potential source ofoxidized 
LDL  (41); perhaps the copper-depleting drug developed for 
the treatment of Wilson's disease of the liver, trientine, could 
possibly have an antiatherosclerotic  effect. Such speculations 
demonstrate the heuristic  value of an evolutionary  perspective 
on the endothelium. We anticipate  that readers of this volume 
will bring a mass of sophisticated knowledge about the prox- 
imate mechanism involved in endothelial diseases. We  hope 
that this chapter will encourage some of them to ask new evo- 
lutionary questions about why the endothelium is the way it is, 
and why it leaves us so vulnerable to such common and devas- 
tating diseases. If they do, progress in endothelial biomedicine 
will occur even faster. 
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